Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab
{{output}}
Background It would be useful to have criteria for predicting long-term treatment responses to immune checkpoint inhibitors (ICIs). Maximum depth of response correlates with treatment outcomes among patients receiving programmed death protein 1 axis inhibitors... ...
